Jones Financial Companies’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.2M | Buy |
228,422
+41,902
| +22% | +$3.85M | 0.01% | 590 |
|
|
2025
Q4 | $16.8M | Sell |
186,520
-19,309
| -9% | -$1.83M | 0.01% | 351 |
|
|
2025
Q3 | $20.2M | Buy |
205,829
+11,045
| +6% | +$1.09M | 0.01% | 297 |
|
|
2025
Q2 | $17.8M | Buy |
194,784
+23,041
| +13% | +$2.23M | 0.01% | 277 |
|
|
2025
Q1 | $19.3M | Buy |
171,743
+50,278
| +41% | +$5.38M | 0.02% | 215 |
|
|
2024
Q4 | $12.8M | Buy |
121,465
+39,931
| +49% | +$4.28M | 0.01% | 223 |
|
|
2024
Q3 | $8.82M | Buy |
81,534
+79,584
| +4,081% | +$8.69M | 0.01% | 222 |
|
|
2024
Q2 | $212K | Sell |
1,950
-5,065
| -72% | -$597K | ﹤0.01% | 816 |
|
|
2024
Q1 | $926K | Buy |
7,015
+4,667
| +199% | +$583K | ﹤0.01% | 271 |
|
|
2023
Q4 | $286K | Buy |
2,348
+428
| +22% | +$47.8K | ﹤0.01% | 291 |
|
|
2023
Q3 | $215K | Sell |
1,920
-137
| -7% | -$17.4K | ﹤0.01% | 259 |
|
|
2023
Q2 | $299K | Buy |
2,057
+113
| +6% | +$15.4K | ﹤0.01% | 241 |
|
|
2023
Q1 | $251K | Buy |
1,944
+110
| +6% | +$13.8K | ﹤0.01% | 256 |
|
|
2022
Q4 | $234K | Buy |
1,834
+70
| +4% | +$8.12K | ﹤0.01% | 251 |
|
|
2022
Q3 | $184K | Buy |
1,764
+179
| +11% | +$19.6K | ﹤0.01% | 251 |
|
|
2022
Q2 | $167K | Buy |
1,585
+64
| +4% | +$7.59K | ﹤0.01% | 252 |
|
|
2022
Q1 | $195K | Sell |
1,521
-272
| -15% | -$32.8K | ﹤0.01% | 251 |
|
|
2021
Q4 | $221K | Buy |
1,793
+322
| +22% | +$42.1K | ﹤0.01% | 240 |
|
|
2021
Q3 | $209K | Sell |
1,471
-106
| -7% | -$15.6K | ﹤0.01% | 223 |
|
|
2021
Q2 | $246K | Buy |
1,577
+119
| +8% | +$19.3K | ﹤0.01% | 212 |
|
|
2021
Q1 | $227K | Sell |
1,458
-10
| -0.7% | -$1.55K | ﹤0.01% | 214 |
|
|
2020
Q4 | $220K | Buy |
+1,468
| New | +$207K | ﹤0.01% | 205 |
|
|
2020
Q2 | – | Sell |
-2,955
| Closed | -$290K | – | 200 |
|
|
2020
Q1 | $290K | Buy |
2,955
+89
| +3% | +$11.7K | ﹤0.01% | 178 |
|
|
2019
Q4 | $417K | Buy |
2,866
+282
| +11% | +$38.9K | ﹤0.01% | 176 |
|
|
2019
Q3 | $344K | Hold |
2,584
| – | – | ﹤0.01% | 184 |
|
|
2019
Q2 | $296K | Sell |
2,584
-437
| -14% | -$51.2K | ﹤0.01% | 187 |
|
|
2019
Q1 | $374K | Sell |
3,021
-13
| -0.4% | -$1.48K | ﹤0.01% | 175 |
|
|
2018
Q4 | $306K | Buy |
3,034
+121
| +4% | +$13.6K | ﹤0.01% | 188 |
|
|
2018
Q3 | $372K | Buy |
2,913
+169
| +6% | +$20.1K | ﹤0.01% | 183 |
|
|
2018
Q2 | $297K | Sell |
2,744
-5
| -0.2% | -$544 | ﹤0.01% | 186 |
|
|
2018
Q1 | $291K | Sell |
2,749
-9
| -0.3% | -$1.04K | ﹤0.01% | 192 |
|
|
2017
Q4 | $323K | Buy |
+2,758
| New | +$312K | ﹤0.01% | 193 |
|
|
2014
Q4 | – | Sell |
-2,514
| Closed | -$245K | – | 235 |
|
|
2014
Q3 | $245K | Buy |
2,514
+15
| +0.6% | +$1.48K | ﹤0.01% | 216 |
|
|
2014
Q2 | $252K | Hold |
2,499
| – | – | ﹤0.01% | 218 |
|
|
2014
Q1 | $230K | Sell |
2,499
-208
| -8% | -$19.2K | ﹤0.01% | 209 |
|
|
2013
Q4 | $245K | Buy |
2,707
+780
| +40% | +$67.5K | ﹤0.01% | 207 |
|
|
2013
Q3 | $154K | Sell |
1,927
-108
| -5% | -$8.5K | ﹤0.01% | 216 |
|
|
2013
Q2 | $148K | Buy |
+2,035
| New | +$152K | ﹤0.01% | 218 |
|
Other funds holding ZBH
VCM
VPM
Jones Financial Companies's ZBH Position: Q1 2026 in Review
Jones Financial Companies increased its Zimmer Biomet (ZBH) stake by 22% in Q1 2026, buying an estimated $3.85M and bringing the position to 228,422 shares worth $20.2M. The position accounts for 0.01% of the portfolio, ranked #590.
Jones Financial Companies first reported a position in ZBH in Q2 2013 and has held it in 38 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Jones Financial Companies held 228,422 shares of Zimmer Biomet worth $20.2M as of Q1 2026.
- Jones Financial Companies bought 41,902 Zimmer Biomet shares in Q1 2026, an estimated $3.85M.
- Zimmer Biomet made up 0.01% of Jones Financial Companies's portfolio in Q1 2026, its #590 holding.
- Jones Financial Companies first reported a position in Zimmer Biomet in Q2 2013 and has held it in 38 quarters since.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.